StockGlow

Royalty Pharma plc (RPD.MU)

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

51.83+0.00%Healthcare
Compare RPD.MU with
StockGlow Score
97
Bullish
BearishBullish
1 year ago+60.6%

The outlook

Royalty Pharma plc currently reads as bullish based on above its 50- & 200-day averages, 100% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$29.85B
52-wk high
51.83
52-wk low
0.00
50-day avg
48.66
200-day avg
39.97
Trailing P/E
31.0

Similar stocks

UNC.FUCB SA$224.30-9.99%TE1.FBio-Techne Corporation$62.52+0.58%RPD.FRoyalty Pharma plc$50.01-2.69%DUL.FAlnylam Pharmaceuticals, Inc.$178.20-28.66%49BA.FBeOne Medicines AG$276.00-2.13%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy